Brilliant’s R&D team endeavours to develop advanced vaccines suitable for all animal species. The focus is on leveraging new technologies and science to come up with a robust pipeline of safe, comprehensive and effective vaccines.

The experienced team brings to the lab vast expertise in vaccinology, molecular biology, bioprocess, assay and clinical development.

The Company’s R&D facility is certified by the Department of Scientific & Industrial Research (DSIR), Government of India, and ably supports their incessant exploration of novel ideas that can become game-changers in the field of biotech-based animal health products.

Brilliant has a robust lineup of new products or
product combinations ready for launch including :

• Bluetongue Vaccine
• PPR Vaccine
• Sheep Pox Vaccine
• FMD+HS and FMD+HS+BQ Vaccines
• Bivalent Pasteurella Vaccine
• Multi-component Clostridial Vaccine
• Combination Vaccines for Companion Animals
• Classical Swine Fever Vaccine
• Goat Pox Vaccine